These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 6364769

  • 1. Metabolism of flecainide.
    Conard GJ, Ober RE.
    Am J Cardiol; 1984 Feb 27; 53(5):41B-51B. PubMed ID: 6364769
    [Abstract] [Full Text] [Related]

  • 2. Biotransformation and elimination of 14C-flecainide acetate in humans.
    McQuinn RL, Quarfoth GJ, Johnson JD, Banitt EH, Pathre SV, Chang SF, Ober RE, Conard GJ.
    Drug Metab Dispos; 1984 Feb 27; 12(4):414-20. PubMed ID: 6148206
    [Abstract] [Full Text] [Related]

  • 3. Clinical pharmacokinetics of the newer antiarrhythmic agents.
    Gillis AM, Kates RE.
    Clin Pharmacokinet; 1984 Feb 27; 9(5):375-403. PubMed ID: 6437721
    [Abstract] [Full Text] [Related]

  • 4. Clinical pharmacokinetics of prazosin.
    Jaillon P.
    Clin Pharmacokinet; 1980 Feb 27; 5(4):365-76. PubMed ID: 6994981
    [Abstract] [Full Text] [Related]

  • 5. Oral flecainide acetate for the treatment of ventricular arrhythmias.
    Anderson JL, Stewart JR, Perry BA, Van Hamersveld DD, Johnson TA, Conard GJ, Chang SF, Kvam DC, Pitt B.
    N Engl J Med; 1981 Aug 27; 305(9):473-7. PubMed ID: 7019711
    [Abstract] [Full Text] [Related]

  • 6. Plasma concentrations of flecainide acetate, a new antiarrhythmic agent, in humans.
    Conard GJ, Carlson GL, Frost JW, Ober RE, Leon AS, Hunninghake DB.
    Clin Ther; 1984 Aug 27; 6(5):643-52. PubMed ID: 6478470
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of lorcainide in man: a new antiarrhythmic agent.
    Klotz U, Müller-Seydlitz P, Heimburg P.
    Clin Pharmacokinet; 1978 Aug 27; 3(5):407-18. PubMed ID: 699462
    [Abstract] [Full Text] [Related]

  • 8. Effects of congestive heart failure on the pharmacokinetics and pharmacodynamics of antiarrhythmic agents.
    Woosley RL, Echt DS, Roden DM.
    Am J Cardiol; 1986 Jan 31; 57(3):25B-33B. PubMed ID: 3080860
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Altered pharmacokinetics of oral flecainide by cimetidine.
    Tjandra-Maga TB, van Hecken A, van Melle P, Verbesselt R, de Schepper PJ.
    Br J Clin Pharmacol; 1986 Jul 31; 22(1):108-10. PubMed ID: 3741720
    [Abstract] [Full Text] [Related]

  • 12. Oral flecainide pharmacokinetics in patients with impaired renal function.
    Forland SC, Burgess E, Blair AD, Cutler RE, Kvam DC, Weeks CE, Fox JM, Conard GJ.
    J Clin Pharmacol; 1988 Mar 31; 28(3):259-67. PubMed ID: 3129455
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Relationship between plasma concentrations and suppression of ventricular extrasystoles by flecainide acetate (R-818), a new antiarrhythmic, in patients.
    Conard GJ, Cronheim GE, Klempt HW.
    Arzneimittelforschung; 1982 Mar 31; 32(2):155-9. PubMed ID: 7199921
    [Abstract] [Full Text] [Related]

  • 16. Flecainide: a new antiarrhythmic drug.
    Mueller RA, Baur HR.
    Clin Cardiol; 1986 Jan 31; 9(1):1-5. PubMed ID: 3510788
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Flecainide: a new agent for the treatment of ventricular arrhythmias.
    Grubb BP, Tilley-Gray B.
    Am J Med Sci; 1986 Sep 31; 292(3):160-3. PubMed ID: 3529958
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.